Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 23

Showing 23 citing articles:

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
Xiaoling Wang, Lijuan Wang, Haihong Lin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
The growing field of liquid biopsy and its Snowball effect on reshaping cancer management
Roberto Borea, Carolina Reduzzi
The Journal of Liquid Biopsy (2025), pp. 100293-100293
Open Access | Times Cited: 1
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Klaus Pantel, Catherine Alix‐Panabières
Nature Reviews Clinical Oncology (2024) Vol. 22, Iss. 1, pp. 65-77
Closed Access | Times Cited: 6
Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
ErinMarie O. Kimbrough, Julian A. Marin‐Acevedo, Leylah Drusbosky, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2366-2366
Open Access | Times Cited: 4
Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine
Jibran Ahmed, Carlos Torrado, Anca Chelariu, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 4
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Fusion genes in cancers: Biogenesis, functions, and therapeutic implications
Haoneng Tang, Peng Qiu, Linda Oyang, et al.
Genes & Diseases (2025), pp. 101536-101536
Open Access
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M. Ernst, Mihaela Aldea, Jan H. von der Thüsen, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Clinical characterization and therapeutic targeting of fusion genes in oncology
Susan Morand, Lauren Elizabeth Rager, Daniel J. Craig, et al.
Future Oncology (2025), pp. 1-12
Open Access
Biomarkers and Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy
Naoshi Nishida
Cancers (2025) Vol. 17, Iss. 7, pp. 1243-1243
Open Access
Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring
Jacqueline V. Aredo, Ayaan M. Jamali, Jessica Zhu, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100140-100140
Open Access | Times Cited: 3
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers
Michela Verzè, Andrea Boscolo Bragadin, Roberta Minari, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100143-100143
Open Access | Times Cited: 2
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Manali Bhave, Júlia C.F. Quintanilha, Hanna Tukachinsky, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 599-609
Open Access | Times Cited: 2
Exosomal microRNAs in lung cancer: a narrative review
Zhe Zhang, Fengwu Lin, Wenqi Wu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3090-3105
Open Access | Times Cited: 2
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
Monica F. Chen, Soo‐Ryum Yang, Jessica J. Tao, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3812-3823
Closed Access | Times Cited: 2
Overview of the role of liquid biopsy in non-small cell lung cancer (NSCLC)
Aylen Vanessa Ospina
Clinical Oncology (2024) Vol. 36, Iss. 10, pp. e371-e380
Closed Access | Times Cited: 2
Molecular tumor board in patients with metastatic breast cancer
Luca Boscolo Bielo, Elena Guerini‐Rocco, Edoardo Crimini, et al.
Breast Cancer Research and Treatment (2024) Vol. 210, Iss. 1, pp. 45-55
Closed Access | Times Cited: 2
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors
W. Li, Yongsheng Wang, Anwen Xiong, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Analytic validation of an FGFR-focused cell-free DNA liquid biopsy assay (FGFR-Dx)
Julie W. Reeser, Michele R. Wing, Eric Samorodnitsky, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients
Ronan Wenhan Hsieh, Lynn Symonds, Jason J. Siu, et al.
International review of cell and molecular biology (2024), pp. 43-93
Closed Access
Coupling of Some Carbazole Analogs with 3pjc Protein Surface as JAK3 Inhibitors
Lauro Figueroa-Valverde, Rosas‐Nexticapa Marcela, Catalina Cervantes-Ortega, et al.
Clinical Cancer Investigation Journal (2024) Vol. 13, Iss. 4, pp. 7-14
Closed Access
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
Young-Gon Kim, Boram Lee, Changhee Ha, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top